000909234 001__ 909234
000909234 005__ 20230123110641.0
000909234 0247_ $$2doi$$a10.1038/s41531-022-00341-8
000909234 0247_ $$2Handle$$a2128/31744
000909234 0247_ $$2pmid$$a35732679
000909234 0247_ $$2WOS$$aWOS:000814627900001
000909234 037__ $$aFZJ-2022-03078
000909234 082__ $$a610
000909234 1001_ $$0P:(DE-HGF)0$$aSteidel, Kenan$$b0$$eCorresponding author
000909234 245__ $$aLongitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
000909234 260__ $$aLondon [u.a.]$$bNature Publ. Group$$c2022
000909234 3367_ $$2DRIVER$$aarticle
000909234 3367_ $$2DataCite$$aOutput Types/Journal article
000909234 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1673348240_4439
000909234 3367_ $$2BibTeX$$aARTICLE
000909234 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000909234 3367_ $$00$$2EndNote$$aJournal Article
000909234 520__ $$aThe prevailing network perspective of Parkinson's disease (PD) emerges not least from the ascending neuropathology traceable in histological studies. However, whether longitudinal in vivo correlates of network degeneration in PD can be observed remains unresolved. Here, we applied a trimodal imaging protocol combining 18F-fluorodeoxyglucose (FDG)- and 18F-fluoro-L-Dopa- (FDOPA)-PET with resting-state functional MRI to assess longitudinal changes in midbrain metabolism, striatal dopamine depletion and striatocortical dysconnectivity in 17 well-characterized PD patients. Whole-brain (un)paired-t-tests with focus on midbrain or striatum were performed between visits and in relation to 14 healthy controls (HC) in PET modalities. Resulting clusters of FDOPA-PET comparisons provided volumes for seed-based functional connectivity (FC) analyses between visits and in relation to HC. FDG metabolism in the left midbrain decreased compared to baseline along with caudatal FDOPA-uptake. This caudate cluster exhibited a longitudinal FC decrease to sensorimotor and frontal areas. Compared to healthy subjects, dopamine-depleted putamina indicated stronger decline in striatocortical FC at follow-up with respect to baseline. Increasing nigrostriatal deficits and striatocortical decoupling were associated with deterioration in motor scores between visits in repeated-measures correlations. In summary, our results demonstrate the feasibility of in-vivo tracking of progressive network degeneration using a multimodal imaging approach. Specifically, our data suggest advancing striatal and widespread striatocortical dysfunction via an anterior-posterior gradient originating from a hypometabolic midbrain cluster within a well-characterized and only mild to moderately affected PD cohort during a relatively short period.
000909234 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000909234 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000909234 7001_ $$0P:(DE-HGF)0$$aRuppert, Marina C.$$b1
000909234 7001_ $$0P:(DE-HGF)0$$aGreuel, Andrea$$b2
000909234 7001_ $$0P:(DE-Juel1)188400$$aTahmasian, Masoud$$b3$$ufzj
000909234 7001_ $$0P:(DE-HGF)0$$aMaier, Franziska$$b4
000909234 7001_ $$0P:(DE-HGF)0$$aHammes, Jochen$$b5
000909234 7001_ $$0P:(DE-HGF)0$$avan Eimeren, Thilo$$b6
000909234 7001_ $$0P:(DE-HGF)0$$aTimmermann, Lars$$b7
000909234 7001_ $$0P:(DE-HGF)0$$aTittgemeyer, Marc$$b8
000909234 7001_ $$0P:(DE-Juel1)177611$$aDrzezga, Alexander$$b9$$ufzj
000909234 7001_ $$0P:(DE-HGF)0$$aPedrosa, David J.$$b10
000909234 7001_ $$0P:(DE-HGF)0$$aEggers, Carsten$$b11
000909234 773__ $$0PERI:(DE-600)2819218-7$$a10.1038/s41531-022-00341-8$$gVol. 8, no. 1, p. 79$$n1$$p79$$tnpj Parkinson's Disease$$v8$$x2373-8057$$y2022
000909234 8564_ $$uhttps://juser.fz-juelich.de/record/909234/files/s41531-022-00341-8.pdf$$yOpenAccess
000909234 909CO $$ooai:juser.fz-juelich.de:909234$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a University Hospital of Marburg$$b0
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a University Hospital of Marburg$$b1
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a University Hospital of Marburg$$b2
000909234 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)188400$$aForschungszentrum Jülich$$b3$$kFZJ
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)188400$$aHHU Düsseldorf $$b3
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a University Hospital Cologne$$b4
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a University Hospital Cologne$$b5
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a University Hospital Cologne$$b6
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a German Center for Neurodegenerative Diseases$$b6
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a University Hospital of Marburg$$b7
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Max Planck Institute for Metabolism Research, Cologne$$b8
000909234 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177611$$aForschungszentrum Jülich$$b9$$kFZJ
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)177611$$a University Hospital Cologne$$b9
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a University Hospital of Marburg$$b10
000909234 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a University Hospital of Marburg$$b11
000909234 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000909234 9141_ $$y2022
000909234 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-09-03
000909234 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000909234 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-09-03
000909234 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-09-03
000909234 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000909234 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-09-03
000909234 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-11
000909234 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-11
000909234 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-10-13T14:34:28Z
000909234 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-10-13T14:34:28Z
000909234 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-10-13T14:34:28Z
000909234 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-11
000909234 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-11
000909234 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-11
000909234 920__ $$lyes
000909234 9201_ $$0I:(DE-Juel1)INM-7-20090406$$kINM-7$$lGehirn & Verhalten$$x0
000909234 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x1
000909234 980__ $$ajournal
000909234 980__ $$aVDB
000909234 980__ $$aI:(DE-Juel1)INM-7-20090406
000909234 980__ $$aI:(DE-Juel1)INM-2-20090406
000909234 980__ $$aUNRESTRICTED
000909234 9801_ $$aFullTexts